Data Mining for DNA Viruses with Breast Cancer and its Limitation by Ju-Hsin Tsai
Selection of our books indexed in the Book Citation Index 
in Web of Science™ Core Collection (BKCI)
Interested in publishing with us? 
Contact book.department@intechopen.com
Numbers displayed above are based on latest data collected. 
For more information visit www.intechopen.com
Open access books available
Countries delivered to Contributors from top 500 universities
International  authors and editors
Our authors are among the
most cited scientists
Downloads
We are IntechOpen,
the world’s leading publisher of
Open Access books
Built by scientists, for scientists
12.2%
122,000 135M
TOP 1%154
4,800
3 
Data Mining for DNA Viruses with  
Breast Cancer and its Limitation 
Ju-Hsin Tsai 
Central Taiwan University of Science and Technology, and Surgical Department,  
Shian-De General Hospital, No. 420. Yichang Rd.,  
Taiping City, Taichung County 411, 
 Taiwan 
1. Introduction 
Breast cancer is very common worldwide, with 800,000 new cases diagnosed each year 
[Parkin et al,1999]. Among Taiwanese women, breast cancer is the second most common 
form of cancer (Cancer Registry Annual Report in Taiwan,  1998-2002)  and  the  fourth  
leading  cause  of  cancer-related  death  (Public  Health  Annual  Report  in Taiwan, 2002). 
The risk factors for development of breast cancer in Taiwan, a low incidence area, are 
similar to those in a moderate-to-high risk area [Yang et al,1997]. Although there are 
recognized factors that increase the risk of breast  cancer,  its  causes  are  still  unknown  
and  thus  there  is  no  way  of  preventing  it. This  paper  explores the  possibility that 
viruses play a role in development of breast tumors. DNA viruses have been recognized as 
oncogenic in humans: Examples include EBV, which is associated with Burkitt lymphoma 
and nasopharyngeal carcinoma, HPV, which is associated with cervical cancer, and hepatitis 
B virus, which is associated with hepatocellular cancer. Viral DNA sequences have been 
found in breast tumors [Tsai et al,2005, ue et al,2003. Fina et al,2001. Labecque et al,1995. 
Horiuchi et al,1994. Kleer et al,2002], but it is not certain that the presence of the virus is 
related to development of breast tumors because similar sequences have been found in 
normal mammary tissue Tsai et al,2005. Pogo et al,1997]. 
Breast cancer is a multistep disease, and infection with a DNA virus could play a role in one 
or more of the steps in this pathogenic process [Labecque et al,1995]. In addition, it has been 
hypothesized that familial breast cancer and sporadic breast cancer are caused by different 
mechanisms. More recently, the differences between familial and sporadic  breast  cancers  
have  be shown to  be  compatible  with  Knudson’s ‘two - hit’  hypothesis [Knudson,1971. 
Richardson,1997],which suggests that at  least two mutations are required  before a cell 
becomes malignant. The reason  thatwomen with familial predisposition to breast cancer are 
likely to develop it at a younger age and are also morelikely to develop bilateral disease is 
because they have inherited one of the two genetic defects (such as mutation of p53) that are 
required for breast cancer. These women require only one ‘hit’ to get breast cancer, whereas 
women with non-familial breast cancer start with no major mutations and thus need 
two‘hit’ Thisobservation is consistent with the hypothesis that breast cancer is caused in part 
by a virus. One of the ‘hit’required for development of breast cancer may be infection with a O
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breast cancer virus. There are a few reports about the relationship between fibroadenoma 
and virus infection [Kleer et al,2002. Lau et al,2003], but they only investigated EBV 
andfibroadenoma. As far as we know, we are the first to report about relationships among 
multiple viruses and fibroadenoma [Tsai et al,2005]. Thus, the question arises whether or not 
breast tumors (either benign – fibroadenoma – or malignant – breast cancer) are influenced 
by infection with oncogenic viruses. 
2. Materials and methods 
In the current study, we explored possible relationships among DNA viruses with breast 
cancer, fibroadenoma,  and  normal  mammary  tissue  with  106  data  points  (tissue  
samples), including 62 specimens of non- familial invasive ductal breast cancer from women 
and 32 mammary fibroadenomas and 12 normal mammary tissues from women cared for at 
Chung-Shan Medical University Hospital, with tissues collected as previously described  [3].  
DNA  extraction,  Polymerase  Chain  Reaction  (PCR)  assay,  and  Southern  Hybridization  
as described previously [Tsai et al , 2005] were applied here. Genome regions, primers, and 
thermal cycler programs for iden- tification of each virus (e.g., HSV-1, EBV, CMV, HPV, and 
HHV-8) were listed in the previous report [Tsai et al , 2005]. 
Using PCR and Southern hybridization, 69 breast cancer and 44 non-breast cancer 
specimens were screened for the presence of, β-globin, the internal control. However, five 
breast cancer tissue samples had negative results for β-globin, and the two breast cancer 
specimens from patients with familial histories of breast cancer were excluded from the 
study. All 44 non-breast cancer specimens were positive for. β-globin. Among the 62 breast 
cancer samples, 8 (12.90%) were positive for HSV-1, 28 (45.16%) for EBV, 47 (75.81%) for 
CMV, 8 (12.90%) for HPV, and 28 (45.16%) for HHV-8. In the non-breast cancer control 
groups, 8/12 (66.67%) were CMV-positive  normal  samples,  whereas  the  results  for  
fibroadenoma samples (total, 32) were 20 (62.50%)HSV-1-positive, 16 (50.00%) EBV-positive,  
20  (62.50%) CMV-positive, 2 (6.25%) HPV-positive, and 28 (87.50%) HHV-8-positive. 
We  submitted  a  data  mining  approach  to  the  current  research  that  included  artificial  
neural networks (ANNs)  and  agglomerative  hierarchical  clustering  techniques  (AHCTs).  
With  the  proposed  data  mining approach (named ANN-AHCT hereafter), the different 
combinations of DNA viruses possible in breast cancer, fibroadenoma, and normal 
mammary tissue were classified by ANNs; then, AHCTs clustered the common 
characteristic during the same classification. 
2.1 Artificial neural networks (ANNs) model 
ANNs are composed of processing elements (nodes or neurons) and their connections. The 
nodes are inter- connected layer-wise among themselves. Each node in each successive layer 
receives the inner product of synaptic weights with the outputs of the nodes in the previous 
layer. The operation of single node is shown in Fig. 1. ANNs  have  been  shown  to  be  
effective  for  addressing  complex  nonlinear  problems. The  two  types of learning 
networks are supervised and unsupervised. For a supervised learning network, a set of 
training input vectors with a corresponding set of target vectors is trained to adjust weights 
in the ANN. For an unsupervised learning network, a set of input vectors is proposed; 
however, no target vectors are specified. In this study, a supervised learning network was 
thought to be more suitable for the classification problem. Several well-known  supervised  
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learning  ANNs  are  the  back-propagation  (BP),  learning  vector  quantization,  and 
counter propagation network. The BP model is used most extensively and can provide 
better solutions for many applications [Lippmann,1987. Dayhoff,1990]. Therefore, the BP 
model was selected for the current study. 
A BP neural network consists of three or more layers, including an input layer, one or more 
hidden layers, and an output layer. Fig. 2. illustrates a basic BP neural network with three 
layers. BP neural network learning works on a gradient-descent algorithm  [Funahashi, 
1989]. The  BP  neural  network  initially  receives  the  input  vector  and directly passes it 
into the hidden layer(s). Each element of the hidden layer(s) is used to calculate an 
activation value by summing up the weighted input, and the sum of the weighted input will 
be transformed into an activity level by using a transfer function. Each element of the output 
layer is then used to calculate an activation value by summing up the weighted inputs 
attributed to the hidden layer. Next, a transfer function is used to calculate the network 
output. The actual network output is then compared with the target value. The BP neural 
network algorithm refers to the propagation of errors of nodes from the output layer to 
nodes in the hidden layer(s).These errors are used to update the network weights. The 
amount of weights to be added to or subtracted from the previous weight is governed by the 
delta rule. After the knowledge representation is determined, the BP neural network will be 
trained to attempt the classification behavior. The number of hidden layers and the number 
of nodes in each hidden layer are determined during the training phase. In this study, a 
fully connected feedforward neural network was used, and its network parameters and 
stopping criterion were set. 
 
 
Fig. 1. Node operation 
To be able to attempt the classification behavior, a learning rule needs to be used in the BP 
neural network. In the case of a multi-layer perception, this rule should also be able to adapt 
the weights of all connections in order to model a nonlinear function. The learning rule used 
most frequently for this purpose is the BP rule. It acts through the following two steps. First, 
the generalized difference D *(t)  is calculated by 
 
(1) 
where *
i
A  is the desired activation of output unit i, and *
i
A (t) is the generated activation of 
this unit. In order to obtain the generalized difference the calculated difference *
i
A (t) - Ai(t) 
is multiplied by the simplified derivative of the activation function Ai(t)* (1 -Ai(t)). Second, 
the generalized differences of the units in the output layer are propagated back through the 
weighted connections to the units of the hidden layer(s). The generalized difference 
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collected from a hidden unit is multiplied by the simplified derivative of the unit’s 
activation function in order to obtain the generalized difference of the hidden unit  
 
(2) 
Using the generalized difference D*(t), the weights are adjusted by 
 
(3) 
The adaptation size of the weight Wij(t) of the connection used to send information from 
unit j to unit i is influenced by the existing weight Wij(t), the learning rate C, the generalized 
difference 
*
i
D (t), and the actual activation Aj(t) of unit j. To reduce the probability of weight 
change oscillation, a weight momentum term is added to adjust the weight. The weight 
momentum term is constructed by previous adjustment of the weight D*Wij(t) and a 
constant value B, so 
 
(4) 
 
 
Fig. 2. A back-propagation (BP) neural network 
If more hidden layers are implemented, the BP rule will use the generalized differences of the 
hidden units of the BP neural network to get the hidden units of the hidden layer closer to the 
input layer. To test the network, test set data are assigned to the networks, and then the output 
is evaluated. The network should be able to interpolate and, possibly, extrapolate. 
In this study, through the above-mentioned principle for construction of a BP model, we 
collected training and testing patterns by randomly selecting data from the total number of 
106 (specimens, or data points) to correlate  the  presence  of  DNA  viruses  with  breast  
cancer,  fibroadenoma,  and  normal  mammary  tissue  to develop a BP model that could 
obtain underlying relationships. The BP model can be constructed without requiring any 
assumptions concerning the functional form of the relationship among the DNA viruses 
with breast cancer, fibroadenoma, or normal mammary tissue. The developed BP model can 
classify the behavior of all possible combinations of DNA viruses. Then, all possible DNA 
virus combinations in the developed classification model would be presented and the 
estimated probability of breast tumor (benign or malignant) would be computed. 
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2.2 Agglomerative hierarchical clustering techniques (AHCTs) 
AHCTs are a statistical method that serially fuses n individuals into groups in order to 
obtain partitions. When  AHCTs  have  placed  two  individuals  into  the  same  group,  the  
two  individuals  cannot  subsequently appear in different groups, that is, the AHCT 
procedure is irreversible. AHCTs’ main objective is to organize data in order to form clusters 
that contain all individuals. In this project, AHCTs were applied to cluster DNA viruses  
that  belong  to  the  same  classification  based  on  the  ANN’s  classification  behavior.  The  
decision- maker’s  duty  is  to  seek  the  ‘best’ fitting  number  of  clusters  needed  to  decide  
how  to  organize  data.  The AHCT procedure is as follows [Salton,1989]: 
Pn, Pn 1, ... , P1 represents a series of partitions of data. The first, Pn, includes n single member 
clusters, and the last, P1, includes a single group that contains all n individuals. The basic 
operation to form Pn, Pn 1, ... , P1 is similar. 
STEP 0: Each cluster C1, C2, ... , Cn includes a single individual. 
STEP 1: To find the nearest pair of distinct clusters, say Ci  and Cj, then to merge Ci and Cj, 
and to delete Cj, decrease the number of clusters by one. 
STEP 2: If the number of clusters equals one then stop, or else return to STEP 1. 
Three inter-group measures of AHCTs differ primarily in the distances between or 
similarity of two clusters. 
One is single linkage clustering (5), another is complete linkage clustering (Eq. 6), and the 
other is average linkage clustering (Eq. 7) [Bunke & Shearer,1998. Wallis et al,2001 ]. 
 
(5) 
 
(6) 
where dAB is the distance between two clusters A and B, and dij is the distance between 
individuals i and j. (This could be a Euclidean distance or one of a variety of other distance 
measures.) 
 
(7) 
where nA  and nB  are the number of individuals in clusters A and B. 
The average linkage cluster is the same as single linkage or complete linkage. However, 
the cluster criterion of the average linkage cluster is the average distance from all 
individuals in one cluster to all individuals in another.  Unlike  single  linkage  clustering  
and  complete  linkage  clustering,  average  linkage  clustering  does not depend on 
extreme values to partition all members of the cluster. The other merit for using the 
average linkage approach is to form clusters with small within-cluster variation. Average 
linkage clustering also tends to be biased toward production of clusters with 
approximately the same variance. So, the authors of the current work considered the 
average linkage cluster’s advantages and the steps of computing Eq. (7) to further cluster 
the DNA viruses in the ANN-AHCT approach. 
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2.3 The proposed ANN-AHCT approach 
In order to obtain the relationship among combinations of DNA viruses with breast cancer, 
fibroadenoma, and normal mammary tissue, an effective and feasible data mining method, 
the ANN-AHCT approach, was proposed. It includes two phases that are summarized in 
Fig. 3, which shows the structure of the ANN-AHCT approach flow chart. 
 
 
Fig. 3. The flow chart ANN-AHCT approach. 
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Phase I. Using the BP model to classify all combinations of DNA viruses. 
To define the knowledge representation, network parameters and stopping criterion is most 
important to obtain  the  best  classification  BP  model.  The  knowledge  representation  
defines  the  relationship  among  the DNA  viruses  with  breast cancer, fibroadenoma,  and 
normal  mammary  tissue. The  number  of input nodes is equal to the number of DNA 
viruses (five, HSV-1, EBV, CMV, HPV, HHV-8); the input values are the value of (positive, 
negative) DNA viruses. In addition, the number of output nodes is three (breast cancer, 
fibroadenoma, and normal mammary tissue); the output values are the code. This means 
that if breast cancer is present, the code is 1, otherwise, the code is 0; similarly, if 
fibroadenoma is present, the code is 1, otherwise, the code is 0; if normal mammary tissue is 
present, the code is 1, otherwise, the code is 0. In addition, the network parameter-learning 
rate and moment will be set to assist the trained network to attempt convergence 
andstabilization in classification behavior. 
The stopping criterion is set to lower the root mean square error (RMSE) in the training and 
testing processes. In this study, in order to obtain the appropriate BP model, the iteration 
was set to 10,000 and the learning rate was set to dynamically auto-adjust from 0.01 to 0.3 
for rapid effective learning and stable behavior as observed  by  mildly varying  values  of  
RMSE.  Table  1  lists  these  appropriate  BP  architectures  and  their momentums. 
In order to obtain the best BP model from Table 1, selection of the best classification model is 
done through selecting the lowest RMSE of training and testing or the highest classification 
correction rate. The architecture (input nodes-hidden nodes-output nodes) 5-2-3 was 
selected to obtain a better performance. In order to obtain the  relationship among each  
different combination of DNA viruses with breast cancer, fibroadenoma, and normal 
mammary tissue, the total number 32 (2 * 2 * 2 * 2 * 2, the combination of DNA viruses) was 
inputted into the architecture 5-2-3, and then the classification of breast tumor and 
occurrence probability could be obtained.  Placement  of  all  DNA  virus  combinations  into  
Tables 2–5 depended on the possible occurrence probability of breast cancer, fibroadenoma, 
and normal mammary tissue. 
In Table 2, 10 DNA virus combinations would result in the highest probability of 
fibroadenoma; in Table 3, 15 DNA virus combinations would result in the highest 
probability of breast cancer; and in Table 4, 4 DNA virus combinations would result in a 
higher probability of breast cancer than of normal mammary tissue, a value  that  was  also  
higher than the probability of fibroadenoma. In Table 5, 3 DNA virus combinations resulted 
in a higher probability of breast cancer or fibroadenoma, that is, a breast tumor. 
Phase II. Using average linkage clustering to obtain different clusters during each 
classification. 
In order to obtain the common combination for each classification, further clustering of each 
classification was necessary. This study used average linkage clustering to obtain different 
clusters in each classification. In Tables 2 and 3, the results of average linkage clustering  
were computed and  depicted the possible cluster results shown in Tables 6 and 7. To decide 
the best number of clusters in Table 6, a medical expert in breast tumors at the Chung-Shan 
Medical University Hospital suggested that three clusters would be best. The first cluster is 
labeled 10 and 12. The second cluster is labeled 26, 28, 30, and 32. The third cluster is labeled 
18, 20, and 24. The label 27 was clustered in the three clusters with difficulty. In addition, to 
decide the best number of clusters in Table 7, the medical expert suggested that four clusters 
would be best. The first cluster is labeled 2,4, 6, and 8. The second cluster is labeled 9 and 11. 
The third cluster is labeled 13, 15, 29, and 31. The fourthcluster is labeled 17, 19, 21, and 23. 
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The label 14 was clustered in the four clusters with difficulty. In Table 3, where the 
combination included only four situations, it was not necessary to further cluster. Similarly, 
in Table5, the combination included only three situations, so it was not necessary to further 
cluster. 
Using used Kendall’s tau-b test to examine the correlation between number of virus 
infections and survivals in breast cancer patients. The results suggest that the number of 
infecting viruses is related to the overall and relapse-free survivals of breast cancer patients 
(correlation coefficient=-0.275; P=0.021). In order to further investigate the relationship 
between viral factors and overall and relapse-free survivals in our sample of breast cancer 
patients, univariate log-rank analysis was used. Both overall and relapse-free survival rates 
were significantly different (P=0.001 and P=0.000, respectively; Table 9) comparing V0, V1, 
V2, V3 and V4 subgroups (zero, one, two, three and four virus infections, respectively). 
 
Architecture (nodes) 
input-hidden-output 
Momentum RMSE  Correction rate (%) 
  Training Testing  
5-1-3 0.52 0.02358 0.02334 89 
5-2-3 0.45 0.02227 0.02241 93 
5-3-3 0.63 0.02587 0.02432 85 
5-4-3 0.43 0.02262 0.02258 93 
5-5-3 0.60 0.02428 0.02518 85 
5-6-3 0.55 0.02344 0.02488 89 
Iteration 10,000.     
Learning rate 0.01–0. 
Table 1. Network options for current study 
 
Label HSV-1 EBV CMV HPV HHV-8 Breast cancer
Normal 
mammary 
Fibroadenoma 
       tissue  
10 - + - - + 0.10 0.00 0.90 
12 -    - + - + + 0.02 0.00 0.98 
26 + + - - + 0.00 0.00 1.00 
28 + + - + + 0.00 0.00 1.00 
30 + + +  + 0.00 0.00 1.00 
32 + + + + + 0.00 0.00 1.00 
18 + - - - + 0.01 0.00 0.99 
20 + - - + + 0.00 0.00 1.00 
24 + - + + + 0.16 0.00 0.84 
27 + + - + - 0.28 0.00 0.72 
 
Table 2. DNA virus combinations for fibroadenoma 
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Label HSV-1 EBV CMV HPV HHV-8 Breast cancer
Normal 
mammary tissue
Fibroadenoma 
2 - - - - + 0.96 0.00 0.04 
4 - - - + + 0.90 0.00 0.10 
6 - - + - + 1.00 0.00 0.00 
8 - - + + + 0.99 0.00 0.01 
9 - + - - - 0.99 0.00 0.01 
11 - + - + - 0.99 0.00 0.01 
13 - + + - - 0.99 0.00 0.01 
15 - + + + - 0.99 0.00 0.01 
29 + + + - - 0.97 0.00 0.03 
31 + + + + - 0.92 0.00 0.08 
17 + - - - - 0.98 0.00 0.02 
19 + - - + - 0.98 0.00 0.02 
21 + - + - - 0.99 0.00 0.01 
23 + - + + - 0.99 0.00 0.01 
14 - + + - + 0.79 0.00 0.21 
Table 3. DNA virus combinations for breast cancer 
Label HSV-1 EBV CMV HPV HHV-8 Breast cancer
Normal mammary 
tissue 
Fibroadenoma 
1 - - - - - 0.59 0.28 0.12 
3 - - - + - 0.69 0.21 0.10 
5 - - + - - 0.50 0.36 0.14 
7 - - + + - 0.61 0.27 0.12 
Table 4. DNA virus combinations and probability for breast cancer 
Label HSV-1 EBV CMV HPV HHV-8 Breast cancer
Normal mammary 
tissue 
Fibroadenoma 
16 - + + + + 0.50 0.00 0.50 
22 + - + - + 0.43 0.00 0.57 
25 + + - - - 0.60 0.00 0.40 
Table 5. DNA virus combinations and probability of breast cancer or fibroadenoma 
Cluster (total) {Label} 
1 {24, 20, 18, 32, 30, 28, 26, 12, 10} 
2 {24, 20, 18} {32, 30, 28, 26, 12, 10} 
3 {24, 20, 18} {32, 30, 28, 26} {12, 10} 
Table 6. Possible total number of clusters for fibroadenoma 
www.intechopen.com
 Data Mining in Medical and Biological Research 
 
48 
Cluster (total) {Label} 
1 {23, 21, 19, 17, 31, 29, 15, 13, 11, 9, 8, 6, 4, 2} 
2 {23, 21, 19, 17, 31, 29, 15, 13, 11, 9} {8, 6, 4, 2} 
3 {23, 21, 19, 17} {31, 29, 15, 13, 11, 9} {8, 6, 4, 2} 
4 {23, 21, 19, 17} {31, 29, 15, 13} {11, 9} {8, 6, 4, 2}
 
Table 7. Possible total number of clusters for breast cancer 
Moreover, as shown in Table 9, significant differences were also demonstrated in 
comparisons of the respective survival rates for the virus infection subgroups: V(0,1), V2, V3 
and V4; V(0, 1), V2, V(3, 4), V(0, 1), V(2, 3), V4, and, V(0, 1) and V(2, 3, 4) (P<0.005 or <0.001) 
(n, n+1.., indicates virus number). Except for the V0 vs. V1 vs. V2 vs. V3 vs. V4 variable, only 
when V(0,1) was grouped for comparison with other multiply virus-infected subgroups, 
however, were the overall and relapse-free survivals significantly different. These results 
suggest that the number of virus infections is related to the overall and relapse-free 
survivals in our sample of breast cancer patients, moreover, the overall and relapse-free 
survivals of multiply (more than two) virus-infected breast cancer patients group is 
significantly different from the no virus- or one virus-infected group. 
3. Discussion 
Previous studies have provided direct evidence that viruses exist in human breast tumors 
and suggest that viruses are one risk factor for breast tumors [Tsai et al,2005. Pogo et al,1997. 
Brower, 2004]. However, some of these studies are disputed [Gopalkrishna et al,1996. 
McCall et al,2001]. From the sample data, this study detected DNA of the five viruses HSV-
1, HPV, CMV, EBV, and HHV-8 in some tissue samples from patients with breast cancer or 
fibroadenoma or women with normal mammary tissue. Only CMV was detected in some 
normal mammary tissue samples. In contrast, breast cancer and fibro- adenoma had a much 
higher frequency for the presence of DNA belonging to two or more viruses (76.90% and 
100.00%, respectively) than the presence of DNA from one virus (23.10% and 0.00%, 
respectively). This suggests that multiple viral infection is closely associated with benign or 
malignant breast tumors. Lawson et al. speculated that  EBV  may  enhance  the  action of 
the  human  homologue  of the  mouse  mammary tumor virus (HHMMTV) because it is 
known that some viruses remain dormant unless activity is promoted by the activity of 
another virus [Mckeating et al,1990. Biegalke, Geballe,1991]. Therefore, different viruses 
have different oncogenic potencies in mammary gland tissue. 
In Table 2 showing data from this study, both the HSV-1 and HHV-8 positive group 
(clusters 2 and 3) with or without EBV infection nearly always had the pathological 
diagnosis of fibroadenoma (nearly 99.00%). The first cluster of Table 2 has the same result, 
but with the conditions HSV-1( -), EBV(+), CMV( -), HHV-8(+). In  Table  8,  the  individual  
effect  of  HSV-1  and  HHV-8  is  seen  between  fibroadenoma  and  breast  cancer. The   
HSV-1(+) group shows OR (Odds Ratio) = 0.09, 95%CI  (Confidence Interval) = 0.03–0.25, 
 P (P-value) < 0.001.  The  HHV-8(+)  group  shows  OR = 0.12, 95%CI = 0.04–0.38,  P < 0.001.  
The  individual effect of HSV-1 and HHV-8 between fibroadenoma and breast cancer shows 
that both HSV-1 and HHV-8 positive groups appear to show a strongly protective effect  
against the progression from fibroadenoma to breast cancer. When the combination  
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HSV-1(- ), HHV-8(+) is  compared  with  HSV-1(+), HHV-8(+) for fibroadenoma and breast 
cancer cases, OR = 20.83, 95%CI = 4.88–88.87, P < 0.001. There is a similar difference between 
cluster 1 of Table 2 and cluster 1 of Table 3: Apart from the combination HSV-1(- ), HHV-
8(+),the other condition found to be present was EBV(+), CMV(- ), which was associated 
with a roughly 99.00% probability of fibroadenoma. In our previous report [Tsai et al , 2005], 
when we took the comparative results of the mammary  fibroadenoma  group  with  normal  
tissues  into  account  (data  not  shown),  EBV  was  closely  related  to fibroadenoma (P < 
0.01). Kleer et al. suggested that EBV was associated with fibroadenoma in an 
immunosuppressed population, with infection localized specifically to epithelial cells. Gandhi 
et al. suggested that the replication of CMV in the absence of an effective immune response is 
central to pathogenesis of disease. Therefore, complications such as tumor formation are 
primarily seen in individuals whose immune systems are immature or are suppressed by drug 
treatment or coinfection with other pathogens. In this study,EBV appears to be related closely 
to fibroadenomas in non-immunosuppressed women. In this classification,the prerequisite 
was CMV(+) or CMV(- ). When HSV-1( -), HHV-8(+) accompanied EBV( -) (cluster 1 of Table 
3), there was a greater than 96.00% probability of breast cancer. 
DNA viruses have been recognized as oncogenic in humans, and viral DNA sequences have 
been found in breast tumors [Tsai et al,2005. Kleer et al,2002]. Different viruses have 
different carcinogenicity, as has been shown in models of mouse mammary cancer induced 
by 7.12-dimethylbenz(a)anthrance (DMBA). Qing et al. gave the classical dosage (1mg 
DMBA give once a week for six weeks) intragastrically to female SENCAR mice, with 
resulting high toxicity; the major tumor type was lymphoma. Lowering the dose to 60 
mcg/day produced less toxicity; in terms of tumor type, there was a 75% incidence of 
lymphoma and a 30% incidence of mammary carcinoma. However, 20mcg DMBA given five 
times per week for six weeks resulted in a 65–70% incidence of mammary carcinoma. It is 
known that some viruses remain dormant unless activity is promoted by the presence of 
another virus [Mckeating et al,1990. Biegalke et al,1991]. In contrast, some virus activity may 
be diminished by the presence of another virus. This may be the basis for the different result 
between HSV-1( -), HHV-8(+) with EBV(+) or EBV( -), CMV( -). 
In Table 3, cluster 2 shows HSV-1( -), EBV(+), CMV( -), HHV-8( -). In Table 8, comparing 
HSV-1( -), HHV-8( -) to HSV-1(+), HHV-8(+) yields OR = 48.33, 95%CI = 9.75–239.65, P < 
0.001, showing that the combined effect of HSV-1 and HHV-8 is more likely to be breast 
cancer than fibroadenoma. In this cluster, other prerequisites were EBV(+), CMV( -).  
Labecque et al. and Bonnet  et al. , who detected the presence of EBV  by  PCR,  found  the  
virus  more  frequently  in  malignant  tumors  than  in non-malignant tumors. Disputes 
surrounding some of these studies [Gopalkrishna et al,1996. Chu et al,1998] may be due to 
the focus on the relationship of a single virus with breast cancer. In Table 3, cluster 3 shows 
EBV(+), CMV(+), HHV-8( -) events. Late expo-sure to a common virus, such as human CMV 
[Richardson,1997], or delayed exposure to EBV [Yasui et al,2001] has been suggested as a 
risk factor of breast cancer. In Table 6, the individual effect of HHV-8(+) suggests a strongly 
protective effect on progression from fibroadenoma to breast cancer (OR = 0.12, 95%CI = 
0.04–0.38, P < 0.001). These pre- requisites resulted in a nearly 97.00% probability of breast 
cancer. Cluster 4 of Table 3  shows that  HSV-1(+), EBV( -), HHV-8( -) was a prerequisite. In 
Table 8, which compares  HSV-1(+),  HHV-8( -) to HSV-1(+),  HHV-8(+),  there  is  OR = 
25.00,  95%CI = 5.92–105.58,  P < 0.001  for  the  combined  effect  of  HSV-1 and HHV-8 with 
the greater likelihood of breast cancer than fibroadenoma. Beside these factors, EBV as a 
negative  condition  showed  a  nearly  98.00%  possibility  of  breast  cancer.  Bonnet  et  al.,  
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who  detected EBV by PCR, found EBV was detected more frequently in breast tumors that 
were hormone-receptor negative (P = 0.01). However, it may still be necessary in the study 
of breast tumors to investigate hormonal influences.Moore et al. indicated that a virus was 
oncogenic in the estrogen milieu of female mice of a strain with genetic susceptibility to 
mammary tumors. 
There  is  experimental  evidence  that  insulin,  glucocorticoids,  estrogen,  and  progestins  
synergize  with MMTV in genetically susceptible female mice to cause mammary cancer 
[McGrath et al,1978]. However, insulin and glucocor-ticoids are physiologically required in 
certain amounts and consistently over time. Therefore, there is particular importance in 
estrogen and progesterone and their correlation to breast cancer [McGrath et al,1978]. 
Mastopathia cystica (fibrocystic disease, mammary dysplasia) was induced by DMBA in 
neonatally androgenized female Spraque-Dawley rats [Yoshida, 1994]. In these 
androgenized rats, no corpora lutea were found in the ovaries. The rat mastopathia cystica 
condition varied widely, with two kinds of macroscopically detectable tumor-forming 
lesions (solid and cystic). The development of rat mastopathia cystica was dependent on 
estrogen [Yoshida, 1994]. Although mammary car-cinoma occurred more frequently in 
neonatally non-androgenized rats than did fibroadenoma [Yoshida, 1994. Yoshida et 
al,1980], it seems even mammary tissues induced by the same carcinogen require a specific 
hormonal state to result in a benign or malignant condition. 
In Table 4, the prerequisite was negative status for HSV-1, EBV, and HHV-8. For the three 
combinations either CMV or HPV, neither CMV nor HPV, or both CMV and HPV in the 
absence of any of the first three viruses, carcinogenic potency was not linked absolutely to a 
malignant or benign tumor. Different studies of HPV in breast cancer present conflicting 
results  [Gopalkrishna et al,1996. Morimoto et al,1999]. Yu et al. [Morimoto et al,1999], who 
detected HPV-33 by PCR, suggested that it may be involved in human breast cancer. 
However, the positive rate of HPV-33 in China was 43.75% (14/32), while in Japan it was 
only 8.33% (1/12). Richardson et al. hypothesized that some breast cancers might be caused 
by late exposure to a common virus such as CMV. According Richardson’s hypothesis, in 
breast cancer exposure to the virus could be a ‘‘hit,’’ while other ‘‘hits’’ [Knudson,1971] 
could be genetic susceptibility (such as an inherited mutation of p53) or uninterrupted 
exposure to a combination of estrogen and progesterone. Therefore, absent an enhancing 
factor (HSV-1, EBV, HHV-8), the incidence of breast cancer in this group was only 60.00%. 
In Table 5, there is no prerequisite: Random virus infection in the mammary tissue produces 
an incidence of either breast cancer or fibroadenoma that is almost the same (50.00%). 
However, despite lack of specificity in resulting pathology, viruses are clearly a 
tumorigenesis factor in the mammary gland. Endogenous estrogens are central to the 
etiology of breast cancer [Adami et al,1998] because in the absence of estrogens breast cancer 
does not occur. A recent prospective study of Japanese women indicated that levels of 
serum estrogens were positively correlated with risk of breast cancer. In humans, there are 
strong associations between dietary pattern and level of circulating estrogen, with energy-
rich  diets correlated with high circulating estrogen levels [Kabuto et al,1998].Well-
conducted case–control and ecological studies in populations with a low risk of breast 
cancer such asthose in China, Japan, and Indonesia, have shown that the risk of breast 
cancer is up to seven times higher in women who consume the highest level of  fats and 
energy within  those  populations [Goldin et al,1986.  Hirayama,1978]. Chen and Liaw 
[2002], who conducted an ecological study of dietary fat intake  and  mortality rates  from 
breast  cancer and colorectal cancer in Taiwan, found a positive correlation between fat and 
both breast cancer and colorectal cancer. Lawson et al. [2001] hypothesized that viruses such 
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as HPV and EBV act as cofactors with diet, estrogen, and other hormones in initiation and 
promotion of some types of breast cancer in genetically susceptible women. 
Triple negative breast cancers have more aggressive clinical course than other forms of 
breast cancer and the incidence was 10-15% [Sorlie et al,200 and 2003. Iwase and 
Yamamoto,2008]. In the current study, the viral prereguisites for breast carcinogenesis 
almost showed the single virus-infected events and the incidence was two folds(27.3%) of 
previous studies (data not shown). In the author unpublished data showed that the overall 
and relapse – free survivals of multiple (more than two) virus – infected breast cancer 
patients group is significantly better than the no virus – or one virus infected group. It 
suggest that current method only detect the aggressive factors of the viral prereguisites for 
breast carcinogenesis. 
 
HSV-1     
Negative (-) 12 54 1  
Positive (+) 20 8 0.09 (0.03–0.25) P < 0.001 
HHV-8     
Negative (-) 4 34 1  
Positive (+) 28 28 0.12 (0.04–0.38) P < 0.001 
HSV-1(+) HHV-
8(+) 
20 3 1  
HSV-1(-) HHV-8(+) 8 25 20.83 (4.88–88.87) P < 0.001 
HSV1(+) HHV-8(+) 20 3 1  
HSV1(+) HHV-8(-) 8 30 25.00 (5.92–105.58) P < 0.001 
HSV1(-) HHV-8(-) 4 29 48.33 (9.75–239.65) P < 0.001 
Table 8. Odds ratios and P-values from sample data (breast cancer and fibroadenoma) 
Overall survival                         Relapse-free survival 
Variable 
P value P value 
V0 vs. V1 vs. V2 vs. V3 vs. V4 0.001* ＜0.001* 
V0 vs. V(1, 2) vs. V(3, 4) 0.359 0.189 
V0 vs. V(1, 2, 3) vs. V4 0.645 0.598 
V0 vs. V(1, 2, 3, 4) 0.515 0.979 
V(0,1) vs. V2 vs. V3 vs. V4 0.013* ＜0.001* 
V(0, 1) vs. V2 vs. V(3, 4) 0.005* ＜0.001* 
V(0, 1) vs. V(2, 3) vs. V4 0.005* ＜0.001* 
V(0, 1) vs. V(2, 3, 4) 0.001* ＜0.001* 
V(0, 1, 2) vs. V3 vs. V4 0.543 0.187 
V(0, 1, 2) vs. V(3, 4) 0.288 0.078 
V(0, 1, 2, 3) vs. V4 0.539 0.312 
Table 9. Results of log-rank analysis for overall and relapse-free survival 
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4. Conclusion 
In previous research on the relationships among DNA viruses and breast cancer, 
fibroadenoma, and normal mammary tissue, only statistical analysis was used. However, 
when using statistical methods to classify DNA  viruses  and  predict  their  probability  in  
breast  cancer,  fibroadenoma,  and  normal  mammary  tissue,the  assumption  of  statistics  
is necessary. Thus, statistics may become inappropriate to deal with problems of prediction, 
classification, and cluster in this study setting. In order to overcome this difficulty, our 
approach used an ANN and AHCTs to achieve the research objective. 
Our  findings  suggest  that  in  Taiwan,  at  least,  the  viral  prerequisites  of  HSV-1( -);  
EBV( -),  HHV-8(+);HSV-1(-), EBV(+), CMV( -), HHV-8( -); EBV(+), CMV(+,)  HHV-8( -); and 
HSV-1(+); EBV( -), HHV-8( -) have a role in breast carcinogenesis. HSV-1(+) and HHV-8(+) 
have a strongly protective effect on progression from fibroadenoma to breast cancer. ANN 
and AHCTs seems to be a contributory method for detecting aggressive viral factors but not 
the better one. However, it is likely that infection by multiple viruses is important in 
development of either benign or malignant breast tumors. Further investigation is required 
to clarify which oncogenic viruses have protective effects and to clarify correlation of viral 
factors and hormone status with development of benign and malignant breast tumors. 
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